Dapplix Medical ApS: Financial statements 2022
CVR: 39721597
Source: annual report 2022, Danish Business Authority
01/10/2021 – 30/09/2022
Dapplix Medical ApS (CVR 39721597) has filed annual accounts for 2022. In 2022, the company reported a gross profit of DKK -30,580 and a net result of DKK -30,580 compared with DKK -94,648 the year before. Equity in the 2022 report amounted to DKK -110,482.
- Gross Profit
- DKK -30,580
- Profit/Loss
- DKK -30,580
- Equity
- DKK -110,482
- Total Assets
- DKK 8,518
- Employees
- 0
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2022 | - | -31K | -31K | -110K | 0 |
| 2021 | - | -95K | -95K | -80K | 0 |
| 2020 | - | -10K | -10K | 15K | 0 |
Official annual report
Keep an eye on Dapplix Medical ApS
Get notified instantly about new financial statements, ownership changes, management changes and status changes.
Set up monitoringEvents in 2022
Dapplix Medical ApS has published its annual report for 2021. Gross profit came to DKK -94,648, and the net result was DKK -94,648.
About Dapplix Medical ApS
Dapplix Medical ApS was a Danish company of the type Anpartsselskab based in Hellerup, founded in 2018. The company has been dissolved on 9 May 2025. The company was registered under the industry Engroshandel med medicinalvarer og sygeplejeartikler. According to the 2024 annual report, the company had an average of 0 employees. In 2024, the company reported a gross profit of DKK -11,012 and a net result of DKK -11,012 compared with DKK -17,189 the year before. Equity in the 2024 report amounted to DKK -138,683.